Biovie Inc.
BIVI· Nasdaq
BIVIBiovie Inc.
Filed Feb 13, 2024 · 10-Q · 44 days after period end · 0001520138-24-000069
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$8.40M | -$15.69M | -$5.41M | -$3.06M |
| EPS Diluted | -$0.22 | -$0.50 | -$0.22 | -$0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Feb 13, 2024 · 44 d after period end
